Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent.

E J Bernhard1, J B Mitchell, D Deen

  • 1University of Pennsylvania, Department of Radiation Oncology, Philadelphia 19104, USA. bernhard@mail.med.upenn.edu

Cancer Research
|January 26, 2000
PubMed
Summary

Independent studies found Gadolinium(III) texaphyrin (Gd-tex) did not enhance radiation therapy effectiveness in multiple human tumor cell lines or in vivo tumor models. These findings question Gd-tex

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International guidelines for the delineation of the postoperative clinical target volumes (CTV) for parotid and submandibular gland cancers.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Exploratory Study of Low Resolution Electromagnetic Tomography (LORETA) Real-Time Z-Score Feedback in the Treatment of Pain in Patients with Head and Neck Cancer.

Brain topography·2018
Same author

Proceedings of the inaugural International Summit for Medical Nutrition Education and Research.

Public health·2016
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2015
Same author

Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer.

AJNR. American journal of neuroradiology·2011

Area of Science:

  • Radiobiology
  • Medical Imaging
  • Oncology

Background:

  • Gadolinium(III) texaphyrin (Gd-tex) was previously proposed as a radiosensitizing agent with tumor-targeting and MRI detection capabilities.
  • Initial studies suggested Gd-tex could enhance radiation therapy efficacy.

Purpose of the Study:

  • To independently verify the radiosensitizing potential of Gd-tex in various human tumor cell lines.
  • To assess Gd-tex efficacy under both normoxic and hypoxic conditions.
  • To evaluate Gd-tex effects on tumor response to radiation in vivo.

Main Methods:

  • Tested Gd-tex (20-500 microM for 24h) with irradiation in HT-29 cells and five other human cell lines (U-87 MG, U251-NCI, SW480, A549, MCF-7).
  • Evaluated radiosensitization under hypoxic conditions in MCF-7 and U-87 MG cell lines.

Related Experiment Videos

  • Assessed in vivo tumor response to Gd-tex and radiation in HT-29 xenografts and RIF-1 tumors.

    • Main Results:

    • No significant radiation sensitization was observed in any of the tested human cell lines, including HT-29.
    • Gd-tex did not demonstrate radiosensitizing effects under hypoxic conditions in MCF-7 and U-87 MG cells.
    • In vivo studies showed no radiosensitization in either HT-29 xenografts or RIF-1 tumors following Gd-tex treatment and irradiation.

    Conclusions:

    • The independent studies failed to reproduce the claimed radiosensitizing effects of Gd-tex.
    • Results indicate that Gd-tex is not an effective radiosensitizing agent in the tested preclinical models.
    • The efficacy of Gd-tex as a radiosensitizer is questionable based on these findings.